The Effect of Respiratory Challenge on the BOLD Signal
1 other identifier
interventional
48
1 country
1
Brief Summary
The purpose of this research study is to better understand how blood flow and metabolism are different between normal controls and patients with disease. The investigators will examine brain blood flow and metabolism using magnetic resonance imaging (MRI). The brain's blood vessels expand and constrict to regulate blood flow based on the brain's needs. The amount of expanding and contracting the blood vessels can do varies by age. The brain's blood flow changes in small ways during everyday activities, such as normal brain growth, exercise, or deep concentration. Significant illness or physiologic stress may increase the brain's metabolic demand or cause other bigger changes in blood flow. If blood vessels are not able to expand to give more blood flow when metabolic demand is high, the brain may not get all of the oxygen it needs. In less extreme circumstances, not having as much oxygen as it wants may cause the brain to grow and develop more slowly than it should. One way to test the ability of the blood vessels to expand is by measuring blood flow while breathing in carbon dioxide (CO2). CO2 causes blood vessels in the brain to dilate without increasing brain metabolism. The study team will use a special mask to control the amount of oxygen and carbon dioxide patients breath in so that we can study how their brain reacts to these changes. This device designed to simulate carbon dioxide levels achieved by a breath-hold and target the concentration of carbon dioxide in the blood in breathing patients. The device captures exhaled gas and provides an admixture of fresh gas and neutral/expired gas to target different carbon dioxide levels while maintaining a fixed oxygen level. The study team will obtain MRI images of the brain while the subjects are breathing air controlled by the device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2020
CompletedFirst Submitted
Initial submission to the registry
February 3, 2020
CompletedFirst Posted
Study publicly available on registry
February 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
January 16, 2026
January 1, 2026
7.9 years
February 3, 2020
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cerebral Oxygen Metabolism
From the beginning of the MRI scan to the completion of the MRI scan -- 75 minutes.
Secondary Outcomes (1)
Cerebrovascular Reactivity
From administration of carbon dioxide to end of inhalation of carbon dioxide -- 15 minutes.
Study Arms (2)
Healthy Adults
ACTIVE COMPARATORAdults diagnosed with vascular pathology of the brain
ACTIVE COMPARATORInterventions
The study team will administer inhaled carbon dioxide to the participants during an MRI at a level
Eligibility Criteria
You may qualify if:
- Healthy adult subjects (\>18 years old) OR adult patients (\>18 years old) diagnosed with vascular pathology of the brain willing to participate and sign a consent form.
- Able to participate in MRI scan without sedation
- Not on stimulant medications
- No psychiatric history, as defined by seeing a psychiatrist for medical evaluation and treatment, or taking anti-depressant medications
- No seizure history
- May have occasional headaches if not taking a daily preventative medication for headaches
- Not on vasodilatory medication, such as sildenafil or verapamil
You may not qualify if:
- Subjects refusing to undergo testing
- Subjects with obstructive or resistive lung disease whose PaCO2 at rest is greater than 50mmHg or whose venous serum bicarbonate is greater than 26 mEq/L
- Subjects with pre-existing respiratory or metabolic acidosis
- Subjects who require portable oxygen at rest or with exercise
- Subjects with chronic heart failure or severe pulmonary disease who are unable to climb one flight of stairs due to shortness of breath
- Subjects with severe heart failure or restrictive lung disease with resting respiratory rate over 15 breaths/min 2. Patients that cannot participate in a course of rehabilitation therapy.
- Subjects that cannot undergo an MRI scan due to one of the following indications:
- Pregnancy
- Obtundation, or Coma
- Confusion, Delirium, or Dementia
- Unable to understand or carry out commands regarding keeping still and breathing pattern
- Increased intracranial pressure due to space occupying lesion or obstruction of outflow of CSF
- Claustrophobia
- History of kidney problems
- Pace makers
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University of St. Louis
St Louis, Missouri, 63110, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2020
First Posted
February 6, 2020
Study Start
January 29, 2020
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
January 16, 2026
Record last verified: 2026-01